Do insider buys or analyst revisions predict stock returns?
Measured Sep 24, 2026 · outcomes through Aug 21, 2026
Mostly no. Across 22 measures of Form 4 insider buying and selling on US stocks since 2003, none showed a reliable edge within three months; analyst upgrades and price targets, at most a faint tilt. The one exception is analyst coverage, measured since 2012: over three months, the least-covered fifth of stocks beat the median stock 52 times in 100, the most-covered fifth 49. A small tilt, not a forecast.
Insider buying and selling, measure by measure
From Form 4 filings we built 22 measures, counting only open-market purchases and sales (grants, option exercises and gifts are left out), each from the session after the filing was public: how many insiders bought or sold and for how much, whether a CEO or CFO bought, whether several insiders bought at once, and how long since the last trade. Each was tested over the next session, week, month and three months: 88 readings in all, and 0 of them passed our bar for a measured tendency.
| Measure | Day | Week | Month | 3 months |
|---|---|---|---|---|
| Buying | ||||
| Purchases as a share of insider trades, 90 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| A CEO or CFO bought, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Cluster buying, three or more insiders, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Number of insider purchases, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Value of insider purchases, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Number of insider purchases, 90 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Value of insider purchases, 90 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Distinct insiders buying, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Value of CEO or CFO purchases, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Purchases weighted by role, 30 days | Faint | No measurable edge | No measurable edge | No measurable edge |
| Selling | ||||
| Number of insider sales, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Value of insider sales, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Number of insider sales, 90 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Sales weighted by role, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Cluster selling, three or more insiders, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Net buying and holdings | ||||
| Purchases minus sales, by number, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Purchases minus sales, by value, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Net buying weighted by role, 30 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Change in insider holdings, 90 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| How recent | ||||
| Days since the last insider purchase | Faint | No measurable edge | Faint | Faint |
| Days since the last insider sale | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Days since any insider trade | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
Insider measures by their strongest reading at any horizon
The measures people ask about
Three measures come up most: buying as a share of all insider trades over 90 days, a CEO or CFO buying in the last 30 days, and cluster buying, when three or more insiders buy within 30 days. Over the next week, month and three months, each showed no measurable edge. The only tilt any of them showed was over the next session: faint, not reliable on its own.
What the faint readings say
Of the 13 faint readings, 11 were over the next session, and they ran slightly the other way: stocks with more insider buying did a touch worse the next day. The one longer hint: stocks whose insiders had bought more recently did slightly better over one and three months, the same way in 17 of 24 years over three months. Each is a faint tilt, not reliable on its own.
What this does and does not say
A Form 4 purchase is a real, dated event: an officer or director bought shares with their own money, and the filing says so. Our question is narrower. Once the filing was public, did stocks with more insider buying beat the median stock over the next day to three months? Across the stocks we cover, we could not measure that they did. This study does not test longer horizons, a single filing read in context, or companies outside our universe. Research, not advice.
More signals that describe a stock without predicting itAnalyst coverage: the one measured tendency
Coverage here is the number of research firms that published any rating or price-target action on a stock in the last 180 days, reiterations included. Every Wednesday since 2012 we split the stocks into fifths by it. Over the next three months, the least-covered fifth beat the median stock 52 times in 100 and the most-covered fifth 49 times in 100. On average the least-covered fifth earned +1.56 percentage points against the day's average stock, the most-covered fifth -0.72. Measured across every stock, not only the two end fifths, the relation kept its direction in 14 of 15 years; the gap between the two end fifths alone pointed the same way in 10 of 15. Over a day and a week it showed no measurable edge; over a month, a faint tilt. It is a tilt across hundreds of stocks and a nudge for any one of them. Coverage tends to rise with company size, and this study did not separate the two.
Stocks in fifths by the number of research firms covering them; lowest = fewest. Out of 100; the dashed line is chance.
Percentage points against the same day's average stock, per fifth; lowest = fewest research firms.
For the curious: the rank correlation (IC) between coverage and the next three months' excess return is -0.029, with a t-statistic of -3.4 on non-overlapping dates.
Upgrades, price targets and estimate revisions
Net upgrades over the last 63 days (upgrades minus downgrades, as a share of all rating actions) showed a faint tilt over the next week, in the direction the upgrades pointed, and no measurable edge over the next day, month or three months; over the week it kept its direction in 9 of 15 years. Net price-target raises over the same 63 days and the gap between the median price target and the price showed no measurable edge at any horizon. How long since any analyst last acted showed a faint tilt over three months, the same way as coverage: names analysts had left alone longer did slightly better. Earnings-estimate revisions could not be measured yet: we have collected them for too short a time.
| Measure | Day | Week | Month | 3 months |
|---|---|---|---|---|
| Research firms covering the stock, 180 days | No measurable edge | No measurable edge | Faint | Proven |
| Net upgrades, 63 days | No measurable edge | Faint | No measurable edge | No measurable edge |
| Net price-target raises, 63 days | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Gap to the median price target | No measurable edge | No measurable edge | No measurable edge | No measurable edge |
| Days since the last analyst action | No measurable edge | No measurable edge | No measurable edge | Faint |
| Earnings-estimate revisions, 30 days | Not enough history | Not enough history | Not enough history | Not enough history |
How this was measured
Every Wednesday since 1995, the stocks in our universe are compared on the signal and followed for 1, 5, 21 and 63 trading sessions. A reading counts when the stock beat the median stock on the same day, so chance is always 50 in 100 and a market-wide rally cannot flatter the result. The strength of a relation is a rank correlation (IC) between the signal and the forward return; its t-statistic is taken on non-overlapping dates, and a relation is called proven only when |t| is at least 3, it held in at least 60% of years and it is large enough to matter. With hundreds of tests, a looser bar would pass about one in twenty by luck. Studies run Sep 24, 2026; outcomes measured through Aug 21, 2026.
Research, not advice. A measured tendency across hundreds of stocks is a nudge for any one of them, never a forecast of its price.
Questions
- Does insider buying predict stock returns?
- Not in a way we could measure. Across 22 measures built from Form 4 open-market purchases and sales on US stocks since 2003, none showed a reliable edge over the next day, week, month or three months: 0 of 88 readings passed our bar. 11 measures showed a faint tilt somewhere, not reliable on its own.
- Does CEO insider buying predict stock returns?
- In this data, no. When a CEO or CFO had bought shares in the open market in the last 30 days, the stock showed no measurable edge over the next week, month or three months, measured on US stocks since 2003. The only reading was a faint one-session tilt, not reliable on its own.
- Is cluster buying by insiders a reliable signal?
- Not one we could measure. When three or more insiders bought within 30 days, the stock showed no measurable edge over the next week, month or three months on US stocks since 2003; over the next session, a faint tilt that was not reliable on its own.
- Do analyst upgrades predict stock returns?
- Barely. Net upgrades over the last 63 days, upgrades minus downgrades as a share of all rating actions, showed a faint tilt over the next week and no measurable edge over a month or three months, on US stocks since 2012. Net price-target raises and the gap to the median price target showed no measurable edge at any horizon.
- Do stocks with fewer analysts do better?
- Slightly, as a tilt across many stocks. Since 2012, the fifth of US stocks covered by the fewest research firms beat the median stock over the next three months 52 times in 100; the most-covered fifth, 49 times. Measured across every stock rather than only the two end fifths, the relation kept its direction in 14 of 15 years. Coverage tends to rise with company size, and this study did not separate the two.
- Does this mean insiders have no information?
- No. A Form 4 purchase is a real event, and this study asks a narrower question: whether, once the filing was public, stocks with more insider buying beat the median stock within three months. On US stocks since 2003, 0 of 88 readings passed our bar. Longer horizons and single filings read in context were not tested.
More evidence
References
- Lakonishok, J. and Lee, I. (2001). Are Insider Trades Informative? Review of Financial Studies 14(1).
- Seyhun, H. N. (1986). Insiders' Profits, Costs of Trading, and Market Efficiency. Journal of Financial Economics 16(2).
- Hong, H., Lim, T. and Stein, J. C. (2000). Bad News Travels Slowly: Size, Analyst Coverage, and the Profitability of Momentum Strategies. Journal of Finance 55(1).